CD79A and COVID-19: To further evaluate the specificity of post-SARS-CoV-2 infection antibodies in serum to these two differential immunodominant antigenic sites in spike that were not bound at high frequency in IgG/IgA from COVID-19 expired patients using GFPDL analysis, these peptides were chemically synthesized and analyzed in ELISA (Fig. 4e, f).